Erdafitinib is a tyrosine kinase inhibitor, a targeted therapy indicated for the treatment of some locally advanced or metastatic urothelial cancers.
What's New
Trastuzumab-dttb (Ontruzant®) is a biosimilar monoclonal antibody used in the treatment of some types of breast and gastric cancer.
In this webinar, Dr. Neil Taunk, MD, MS, Assistant Professor and Chief of Gynecologic Radiation Oncology at Penn Medicine, provides an overview of proton radiation therapy for gynecologic cancers.
Trastuzumab and Hyaluronidase-oysk (Herceptin Hylecta™) is a medication used in the treatment of some cases of breast cancer.
OncoLink Apps
Blogs
OncoLink's Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.
View all Blogs
Cancer Awareness
Head & Neck Cancer Awareness Week
Learn more about head & neck cancers in our dedicated section! Smoking and alcohol use have always been associated with head & neck cancers. However, in the past decade, cases in young, non-smokers have been on the rise due to human papillomavirus (learn more about human papillomavirus). Check out the Living Beyond Head & Neck Cancer webinar to learn about survivorship concerns.
Many places host free head & neck cancer screening events in April. Find one near you!
Need Cancer Patient Education Tools?
Our award winning cancer education content is now available for licensing and syndication.
I Wish U Knew!
I Wish U Knew is a video series featuring oncology professionals and survivors discussing what they wish patients and the public knew about cancer.